University of Texas/Texas AM Investment Management Co (UTIMCO)’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-882
Closed -$1.77K 201
2024
Q3
$1.77K Hold
882
﹤0.01% 162
2024
Q2
$1.46K Hold
882
﹤0.01% 170
2024
Q1
$5.33K Hold
882
﹤0.01% 149
2023
Q4
$6.19K Sell
882
-1
-0.1% -$8 ﹤0.01% 163
2023
Q3
$7.72K Hold
883
﹤0.01% 96
2023
Q2
$10K Hold
883
﹤0.01% 12
2023
Q1
$15K Hold
883
0.01% 14
2022
Q4
$23K Hold
883
0.01% 43
2022
Q3
$90K Hold
883
0.03% 15
2022
Q2
$125K Hold
883
0.05% 10
2022
Q1
$139K Hold
883
0.07% 11
2021
Q4
$196K Hold
883
0.09% 17
2021
Q3
$170K Hold
883
0.1% 17
2021
Q2
$212K Hold
883
0.16% 12
2021
Q1
$299K Sell
883
-7,944
-90% -$3.23M 0.18% 13
2020
Q4
$3.16M Hold
8,827
3.42% 6
2020
Q3
$4.08M Buy
+8,827
New +$2.49M 4.24% 6

Other funds holding TFFP

University of Texas/Texas AM Investment Management Co (UTIMCO)'s TFFP Position: Q4 2024 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 882 shares — an estimated $1.77K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in TFFP in Q3 2020 and held it in 17 quarters. The position peaked at $4.08M in Q3 2020. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 882 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.77K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 17 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s TFF Pharmaceuticals, Inc. Common Stock position peaked at $4.08M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2024, filed 19 Feb 2025.